Celltrion Group Chairman Jung-Jin Seo lead aggressive movements for Remsima to U.S. market
An event to celebrate the U.S. launch of the Celltrion’s antibody biosimilar, Remsima(U.S. name: Inflectra) was held on the 5th of December(local time) in Las Vegas, USA.
In order to wish a successful launch of Remsima that was first introduced in the U.S. market, Celltrion Group Chairman Jung-J...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
